Allergic Diseases Research Group

Grupo de investigación clínico y básico en enfermedades alérgicas.

[Allergic Diseases Research Group @ADRGMalaga]

Very happy with the representation of our group at the #EAACI2024 congress in Valencia. Congratulations to the researchers of the group who have won some of the awards for best communications! @Nano_boticario @Maribelmv12 @silca_95 @JoseCespedes13 @alergosur_es

[Allergic Diseases Research Group @ADRGMalaga]

Muy contentos con la representación de nuestro grupo en el congreso #EAACI2024 en Valencia. ¡Enhorabuena a los investigadores del grupo que han ganado alguno de los premios a mejores comunicaciones! @Nano_boticario @Maribelmv12 @silca_95 @JoseCespedes13 @alergosur_e

[Allergic Diseases Research Group @ADRGMalaga]

Muy contentos con la representación de nuestro grupo en el congreso #EAACI2024 en Valencia. ¡Enhorabuena a los investigadores del grupo que han ganado alguno de los premios a mejores comunicaciones! @Nano_boticario @Maribelmv12 @silca_95 @JoseCespedes13 @alergosur_e

[Ruben Fernandez Santamaria @rubn1991]

Excited to announce that our latest research on genomic variants associated with #betalactam #allergy has been published in @AllergyEaaci. A fantastic collaboration by members of the @ADRGMalaga group! #research #allergy #drug.

https://t.co/haBkKIvU4c

[Luzma 💜 @Luzma_gp]

Por favor, en @CIBER_ISCIII agradeceríamos máxima difusión de esta Call, mil gracias de antemano!!!

[IBIMA Plataforma BIONAND @_ibima]

Enhorabuena a María José Torres por este nombramiento tan importante 👇🏻

[EAACI JM @EAACI_JM]

👏 Thank you to everyone who made Allergy College 2024 a success! 28 applications, 17 countries, 15 students supported. 🌍 #EAACI2024 #JMA #JM #allergycollege 🧬💉

[EAACI JM @EAACI_JM]

👏Dear JMs, during the period 2022-2024, the Junior Member Assembly has done an incredible work. Thank you for your incredible support! Read about it in the latest #EAACI #Allergy #Immunology #EAACIReview
https://t.co/GoRrlvNcbP

[EAACI @EAACI_HQ]

We are thrilled to announce that Allergy has been named the highest-impact journal in Allergy and Clinical Immunology for 2024, with an impressive Impact Factor of 12.6! 🎉This achievement is thanks to the commitment of the entire Allergy team. A heartfelt #ThankYou! 🌟

[IBIMA Plataforma BIONAND @_ibima]

🔝Nuestra coordinadora científica del área ' Enfermedades autoinmunes, infecciosas, inflamación y alergia' y jefa de servicio de #Alergología de @HRegionalMalaga @ADRGMalaga es la primera profesional española en llegar a este puesto

📰@opiniondemalaga

https://t.co/jFkpHoDavf

[EAACI @EAACI_HQ]

The #EAACICongress 2024 has ended with great success!
Thank you to the 8000 attendees and everyone who joined us.
Under the new presidency of Dr. María José Torres, we look forward to welcoming you to EAACI Congress 2025 in Glasgow!

#Allergy #Immunology #DataScience #Valencia

[Allergy EAACI @AllergyEaaci]

Professor Maria J. Torres, President of the #EAACI giving her inaugural speech and program in the General Assembly of the EAACI this morning.

#eaaci2024

[EAACI JM @EAACI_JM]

📌JMA Event at #Valencia #EAACI2024
After 5 years JMA Party is back!!
We celebrate it at 📍Villa Indiano
#EAACI2024 #EAACIJM

[Allergy EAACI @AllergyEaaci]

The Reviewers’ Retreat of Allergy took place today in Valencia during the EAACI Congress.

Top Reviewers of 2023

Antolin-Amerigo, Dario
Arasi, Stefania
Azkur, Dilek
Azkur, Ahmet
Boonpiyathad, Tadech
Bosco, Julian
Cabanillas, Beatriz
Chaker, Adam
Eggel, Alexander
Eguiluz-Gracia, Ibon
Gillman, Andrew
Matricardi, Paolo
Hoffmann-Sommergruber, Karin
Jimenez-Saiz, Rodrigo
Kita, Hirohito
KleinJan, Alex
Klimek, Ludger
Koplin, Jennifer
Kortekaas Krohn, Inge
Lin, Lin
Liu, Zheng
Loukides, Stelios
Mayorga, Cristobalina
Mediouni, Mohamed
Mitamura, Yasutaka
Morita, Hideaki
Ogulur, Ismail
Özdemir, Cevdet
Palomares, Oscar
Park, Hae-Sim
Pat, Yagiz
Perez de Llano, Luis
Sahiner, Umit
Sekerel, Bulent
Simon, Dagmar
Sokolowska, Milena
Sturm, Gunter
Sugita, Kazunari
Paul, Turner
Upton, Julia
Venter, Carina
Wöhrl, Stefan
Yao, Yin
Zemelka-Wiacek, Magdalena
Zielen, Stefan
Zubrinich, Celia

https://t.co/WsHBrsUyhR

#eaci2024 #allergy_journal

[EAACI @EAACI_HQ]

🚀 Day 3 of the EAACI Congress 2024 in Valencia! 🎉 Amazing lectures, abstract meetings, and research group sessions today. The drive to revolutionize patient care with data science is in full force with 8000 experts! #EAACI2024 #Valencia #PrecisionMedicine #Immunotherapy

[Allergy EAACI @AllergyEaaci]

The #skin is the largest immune organ, acting as a protective layer between the body and the environment. It restricts water loss and prevents the entering of harmful substances to deeper tissues. When environmental pollutants, parasites, and bacteria compromise the skin barrier, alarmins are produced, initiating type 2 immune responses. Microbial dysbiosis of the skin has been observed in atopic dermatitis patients, characterized by a loss of microbial diversity and an overabundance of pathogenic Staphylococcus aureus. This microbial imbalance stimulates the production of inflammatory cells, such as T cells, dendritic cells, and macrophages, contributing to disease severity, and perpetuating inflammation, itching, and further disruption of the skin barrier.
In this issue, Wang et al., in their comprehensive review, highlight the impact of climatic hazards linked to greenhouse gas emissions and atopic dermatitis. Tham et al. review the skin microbiome in pediatric atopic dermatitis and food allergy. Canani et al. provide an overview of the epithelial barriers of the skin, digestive tract, and airways, and explore how barrier dysfunction affects the course of allergic and inflammatory conditions. Müller and Maintz et al., in their review
of treatments for atopic dermatitis, provide an update on recently approved biologics and oral Janus kinase (JAK) inhibitors. Del Duca and Dahabreh et al. evaluate transcriptomics of skin tape-strips in children with allergic asthma and uncover epidermal barrier dysfunction and biomarker abnormalities. Ruchti et al., using a mouse model, demonstrate that epidermal barrier impairment predisposes to excessive growth of Malassezia on the skin. Fritz et al. reveal key differences between tape-strips and biopsies in the identification of gene-expression changes in atopic dermatitis. Guttman-Yassky et al. provide evidence that IL-13 targeting with tralokinumab normalizes type 2 inflammation in atopic dermatitis. Rademacher et al. present a novel role of RNase inhibitor as a trigger factor of inflammation in atopic dermatitis by blocking the ribonuclease and antimicrobial activity of RNase 7, thereby enhancing the growth of Staphylococcus aureus. Jin and Lee et al. describe a novel Th2-proming subset of dendritic cells, particularly prevalent in severe atopic dermatitis. M. Kim, J. Kim, Kang, Heo, and Kang et al. evalute the efficacy and safety of topical Streptococcus postbiotic emollient in atopic dermatitis. Aoyama, Nakagawa, and Ichikawa et al. study the skin dysbiosis in atopic dermatitis from the neonatal stage to infancy. Craig et a. use a naturally occurring canine model of atopic dermatitis to examine IL-31 transcription in the skin over the course of an acute allergic flare and following chronic inflammation. Lam et al. demonstrate that SM17, a new IL-17RB-targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis.

The cover image depicts the colony Staphylococcus aureus. Photo credit: © M Oeggerli 2007, supported by Pathology, Univ. Hosp. Basel and School of Life Sciences, FHNW, Muttenz.

[Ruben Fernandez Santamaria @rubn1991]

The @EAACI_JM has done an incredible job in a great number of meetings, collaborating in different activities and initiatives totally orientated to Junior Members. You can read about it in the last @EAACI_HQ Review Issue 07 #EAACIreview

https://t.co/sg7foT0p9J

[Allergy EAACI @AllergyEaaci]

Allergy is at # EAACI2024 in Valencia!

#allergy_journal

[EAACI JM @EAACI_JM]

Dear Juniors! Welcome to day 3 of the #EAACI2024.
Our JMA6, JMA & NAS joint symposium, will start now in the “Sevilla” room.

[EAACI JM @EAACI_JM]

Dear Juniors! Now it’s time for the JMA5 - Initiatives Symposium, talking about the Mentorship Programme and the Fellowship Programme at the EAACI Global Stage.
#EAACI2024